Trace amine-associated receptor 1 (TAAR1) has emerged as a promising therapeutic target
for neuropsychiatric disorders due to its ability to modulate monoaminergic and …

The discovery in 2001 of a G protein-coupled receptor family, subsequently termed trace
amine-associated receptors (TAAR), triggered a resurgence of interest in so-called trace …

Methamphetamine (METH) is a powerful central nervous system stimulant which elevates
mood, alertness, energy levels and concentration in the short-term. However, chronic use …

Biogenic amines are a collection of endogenous molecules that play pivotal roles as
neurotransmitters and hormones. In addition to the “classical” biogenic amines resulting …

The extensive use of amphetamines to treat attention deficit hyperactivity disorders in
children provides a compelling rationale for understanding the mechanisms of action of …

Trace amines, a group of amines expressed at the nanomolar level in the mammalian brain,
can modulate monoamine transmission. The discovery of and the functional research on the …

Introduction: Methamphetamine use is a serious public health concern in many countries
and is second to cannabis as the most widely abused illicit drug in the world. Effective …

Introduction: The trace amines, endogenous amines closely related to the biogenic amine
neurotransmitters, have been known to exert physiological and neurological effects for …

Continued methamphetamine (MA) use is dependent on a positive MA experience and is
likely attenuated by sensitivity to the aversive effects of MA. Bidirectional selective breeding …

Trace amine-associated receptors (TAARs) are a family of G protein-coupled receptors
(GPCRs) that are evolutionarily conserved in vertebrates. The first discovered TAAR1 is …